Latest Abbott Laboratories Stories
- Reports Second-Quarter Adjusted EPS of $0.82, Above Previous Guidance Range of $0.75 to $0.77 (Reports GAAP EPS of $0.68) NORTH CHICAGO, Ill., July 25, 2014 /PRNewswire/ -- NOT
DUBLIN, July 22, 2014 /PRNewswire/ -- Research and Markets has announced the
DUBLIN, July 22, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/m3xbsf/global_coronary)
The emerging markets including China, India, Brazil, and Mexico have became attractive for the companies engaged in the development and marketing of the hematology analyzers and reagents (
LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- Second-Quarter Ongoing EPS of $0.54, Above Previous Guidance Range and Representing Double-Digit Earnings-Per-Share Growth - ABBOTT PARK, Ill., July 16, 2014 /PRNewswire/ -- Abbott today
Abbott will retain its branded generics pharmaceuticals business in emerging markets ABBOTT PARK, Ill., July 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it will
RnRMarketResearch.com adds “World Glucose Self-Testing Markets” and “U.S. Glucose Testing Markets” to its store.
Global IVD Market 2014-2018, A New Research Report, Added to Sandlerresearch.org Store Dallas, Texas (PRWEB) July 06, 2014 In the recent past, there
DUBLIN, July 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8nwszl/pointofcare)
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.